Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C16H15F3O |
| Molecular Weight | 280.2849 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(O)(C1=CC=CC=C1)C2=CC=CC(=C2)C(F)(F)F
InChI
InChIKey=DVASNQYQOZHAJN-UHFFFAOYSA-N
InChI=1S/C16H15F3O/c1-2-15(20,12-7-4-3-5-8-12)13-9-6-10-14(11-13)16(17,18)19/h3-11,20H,2H2,1H3
| Molecular Formula | C16H15F3O |
| Molecular Weight | 280.2849 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Cytochromes P450 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2238704 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Efficacy of enzyme-inducing agents in experimental tetrachloromethane poisoning]. | 2003-10-16 |
|
| Efficiency of enzyme-inducing agents in rats with intrahepatic cholestasis. | 2002-09 |
|
| [Liver monooxygenase system inducers in the treatment of respiratory distress syndrome in newborn]. | 2002-03 |
|
| [The drop in toxicity and the rise in the effectiveness of antineoplastic chemotherapy by correcting the activity of liver monooxygenases: from the experiment to the clinical practice]. | 2002 |
|
| [Reducing of hepatotoxicity of antineoplastic chemotherapy and concomitant viral infection through control of liver metabolism: from experiment to clinical practice]. | 2001 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7918930
600 mg once weekly for 3 weeks.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:45:33 GMT 2025
by
admin
on
Mon Mar 31 23:45:33 GMT 2025
|
| Record UNII |
FMZ2L5L8WH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FMZ2L5L8WH
Created by
admin on Mon Mar 31 23:45:33 GMT 2025 , Edited by admin on Mon Mar 31 23:45:33 GMT 2025
|
PRIMARY | |||
|
107317-31-7
Created by
admin on Mon Mar 31 23:45:33 GMT 2025 , Edited by admin on Mon Mar 31 23:45:33 GMT 2025
|
PRIMARY |